HRGN insider buying and SEC filings, explained
Harvard Apparatus Regenerative Technology, Inc. · CIK 1563665
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- OTC
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Biostage, Inc.
Insider activity in the last 12 months
Bought
$14K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 11, 2026 | Other purchase | Junli He (CEO and Director) bought 361,905 Common Stock at $1.05 ($380K) in a private placement. Holdings up 38% to 1,326,205 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 25, 2026 |
| Sep 15, 2026 | Purchase (code P) | Junli He (CEO and Director) bought 6,725 shares at about $2.15 ($14K), reported as a purchase (code P). Holdings up 1% to 1,332,930 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 25, 2026 |
| Nov 25, 2025 | Purchase (code P) | Junli He (CEO and Director) bought 3,000 shares at about $1.70 ($5K), reported as a purchase (code P). Holdings up 1% to 280,575 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 1, 2025 |
2 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow HRGN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.